Global Sustained-release Medicine Market Research Report 2026(Status and Outlook)
Sustained-release Medicine refer to preparations that can be continuously released for a long time after administration to achieve long-acting effects, and the drug release is mainly a first-order rate process. Controlled release preparations (controlled release preparations) refer to the preparations that can automatically release the drug at a predetermined speed within a predetermined time, so that the blood drug concentration can be kept constant within the effective concentration range for a long time. Since there is no difference between sustained-release preparations and controlled-release preparations in the some countries, so, in this report, Extended release (ER), Sustained release (SR), Controlled release (CR) and Delayed release (DThe main global manufacturers of sustained-release drugs are Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, etc. The top seven manufacturers occupy a total market share of nearly 35%, of which the largest manufacturer is Sanofi, with a market share of 10.85%. Global sustained-release drug production regions are mainly located in Europe, the United States, China, etc., of which the top two regions occupy more than 65% of the market share. In terms of their product categories, original ground medicine have a higher market share of 63.96%, while generics have a lower share.
The global Sustained-release Medicine market size was estimated at USD 39190.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Sustained-release Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Sustained-release Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Sustained-release Medicine market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Sustained-release Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Sustained-release Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Sustained-release Medicine market size was estimated at USD 39190.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Sustained-release Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Sustained-release Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Sustained-release Medicine market.
Global Sustained-release Medicine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Sanofi
- Novartis
- Bayer
- Johnson & Johnson
- Takeda
- AstraZeneca
- AbbVie
- Pfizer
- Collegium Pharmaceutical, Inc
- Endo Pharmaceuticals
- Shanghai Shyndec Pharmaceutical
- Zhuhai Rundu Pharmaceutical
- China Res Double-Crane
Market Segmentation (by Type)
- Original Ground Medicine
- Generic Medicine
Market Segmentation (by Application)
- Hospital
- Drugstore
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Sustained-release Medicine Market
Overview of the regional outlook of the Sustained-release Medicine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Sustained-release Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Sustained-release Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Sustained-release Medicine
1.2 Key Market Segments
1.2.1 Sustained-release Medicine Segment by Type
1.2.2 Sustained-release Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SUSTAINED-RELEASE MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Sustained-release Medicine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Sustained-release Medicine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SUSTAINED-RELEASE MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Sustained-release Medicine Product Life Cycle
3.3 Global Sustained-release Medicine Sales by Manufacturers (2020-2025)
3.4 Global Sustained-release Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Sustained-release Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Sustained-release Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Sustained-release Medicine Market Competitive Situation and Trends
3.8.1 Sustained-release Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Sustained-release Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SUSTAINED-RELEASE MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Sustained-release Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SUSTAINED-RELEASE MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Sustained-release Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Sustained-release Medicine Market
5.7 ESG Ratings of Leading Companies
6 SUSTAINED-RELEASE MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Sustained-release Medicine Sales Market Share by Type (2020-2025)
6.3 Global Sustained-release Medicine Market Size by Type (2020-2025)
6.4 Global Sustained-release Medicine Price by Type (2020-2025)
7 SUSTAINED-RELEASE MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Sustained-release Medicine Market Sales by Application (2020-2025)
7.3 Global Sustained-release Medicine Market Size (M USD) by Application (2020-2025)
7.4 Global Sustained-release Medicine Sales Growth Rate by Application (2020-2025)
8 SUSTAINED-RELEASE MEDICINE MARKET SALES BY REGION
8.1 Global Sustained-release Medicine Sales by Region
8.1.1 Global Sustained-release Medicine Sales by Region
8.1.2 Global Sustained-release Medicine Sales Market Share by Region
8.2 Global Sustained-release Medicine Market Size by Region
8.2.1 Global Sustained-release Medicine Market Size by Region
8.2.2 Global Sustained-release Medicine Market Size by Region
8.3 North America
8.3.1 North America Sustained-release Medicine Sales by Country
8.3.2 North America Sustained-release Medicine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Sustained-release Medicine Sales by Country
8.4.2 Europe Sustained-release Medicine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Sustained-release Medicine Sales by Region
8.5.2 Asia Pacific Sustained-release Medicine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Sustained-release Medicine Sales by Country
8.6.2 South America Sustained-release Medicine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Sustained-release Medicine Sales by Region
8.7.2 Middle East and Africa Sustained-release Medicine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SUSTAINED-RELEASE MEDICINE MARKET PRODUCTION BY REGION
9.1 Global Production of Sustained-release Medicine by Region(2020-2025)
9.2 Global Sustained-release Medicine Revenue Market Share by Region (2020-2025)
9.3 Global Sustained-release Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Sustained-release Medicine Production
9.4.1 North America Sustained-release Medicine Production Growth Rate (2020-2025)
9.4.2 North America Sustained-release Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Sustained-release Medicine Production
9.5.1 Europe Sustained-release Medicine Production Growth Rate (2020-2025)
9.5.2 Europe Sustained-release Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Sustained-release Medicine Production (2020-2025)
9.6.1 Japan Sustained-release Medicine Production Growth Rate (2020-2025)
9.6.2 Japan Sustained-release Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Sustained-release Medicine Production (2020-2025)
9.7.1 China Sustained-release Medicine Production Growth Rate (2020-2025)
9.7.2 China Sustained-release Medicine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Sustained-release Medicine Product Overview
10.1.3 Sanofi Sustained-release Medicine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Sustained-release Medicine Product Overview
10.2.3 Novartis Sustained-release Medicine Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Bayer
10.3.1 Bayer Basic Information
10.3.2 Bayer Sustained-release Medicine Product Overview
10.3.3 Bayer Sustained-release Medicine Product Market Performance
10.3.4 Bayer Business Overview
10.3.5 Bayer SWOT Analysis
10.3.6 Bayer Recent Developments
10.4 Johnson and Johnson
10.4.1 Johnson and Johnson Basic Information
10.4.2 Johnson and Johnson Sustained-release Medicine Product Overview
10.4.3 Johnson and Johnson Sustained-release Medicine Product Market Performance
10.4.4 Johnson and Johnson Business Overview
10.4.5 Johnson and Johnson Recent Developments
10.5 Takeda
10.5.1 Takeda Basic Information
10.5.2 Takeda Sustained-release Medicine Product Overview
10.5.3 Takeda Sustained-release Medicine Product Market Performance
10.5.4 Takeda Business Overview
10.5.5 Takeda Recent Developments
10.6 AstraZeneca
10.6.1 AstraZeneca Basic Information
10.6.2 AstraZeneca Sustained-release Medicine Product Overview
10.6.3 AstraZeneca Sustained-release Medicine Product Market Performance
10.6.4 AstraZeneca Business Overview
10.6.5 AstraZeneca Recent Developments
10.7 AbbVie
10.7.1 AbbVie Basic Information
10.7.2 AbbVie Sustained-release Medicine Product Overview
10.7.3 AbbVie Sustained-release Medicine Product Market Performance
10.7.4 AbbVie Business Overview
10.7.5 AbbVie Recent Developments
10.8 Pfizer
10.8.1 Pfizer Basic Information
10.8.2 Pfizer Sustained-release Medicine Product Overview
10.8.3 Pfizer Sustained-release Medicine Product Market Performance
10.8.4 Pfizer Business Overview
10.8.5 Pfizer Recent Developments
10.9 Collegium Pharmaceutical, Inc
10.9.1 Collegium Pharmaceutical, Inc Basic Information
10.9.2 Collegium Pharmaceutical, Inc Sustained-release Medicine Product Overview
10.9.3 Collegium Pharmaceutical, Inc Sustained-release Medicine Product Market Performance
10.9.4 Collegium Pharmaceutical, Inc Business Overview
10.9.5 Collegium Pharmaceutical, Inc Recent Developments
10.10 Endo Pharmaceuticals
10.10.1 Endo Pharmaceuticals Basic Information
10.10.2 Endo Pharmaceuticals Sustained-release Medicine Product Overview
10.10.3 Endo Pharmaceuticals Sustained-release Medicine Product Market Performance
10.10.4 Endo Pharmaceuticals Business Overview
10.10.5 Endo Pharmaceuticals Recent Developments
10.11 Shanghai Shyndec Pharmaceutical
10.11.1 Shanghai Shyndec Pharmaceutical Basic Information
10.11.2 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product Overview
10.11.3 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product Market Performance
10.11.4 Shanghai Shyndec Pharmaceutical Business Overview
10.11.5 Shanghai Shyndec Pharmaceutical Recent Developments
10.12 Zhuhai Rundu Pharmaceutical
10.12.1 Zhuhai Rundu Pharmaceutical Basic Information
10.12.2 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product Overview
10.12.3 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product Market Performance
10.12.4 Zhuhai Rundu Pharmaceutical Business Overview
10.12.5 Zhuhai Rundu Pharmaceutical Recent Developments
10.13 China Res Double-Crane
10.13.1 China Res Double-Crane Basic Information
10.13.2 China Res Double-Crane Sustained-release Medicine Product Overview
10.13.3 China Res Double-Crane Sustained-release Medicine Product Market Performance
10.13.4 China Res Double-Crane Business Overview
10.13.5 China Res Double-Crane Recent Developments
11 SUSTAINED-RELEASE MEDICINE MARKET FORECAST BY REGION
11.1 Global Sustained-release Medicine Market Size Forecast
11.2 Global Sustained-release Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Sustained-release Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Sustained-release Medicine Market Size Forecast by Region
11.2.4 South America Sustained-release Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Sustained-release Medicine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Sustained-release Medicine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Sustained-release Medicine by Type (2026-2035)
12.1.2 Global Sustained-release Medicine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Sustained-release Medicine by Type (2026-2035)
12.2 Global Sustained-release Medicine Market Forecast by Application (2026-2035)
12.2.1 Global Sustained-release Medicine Sales (K MT) Forecast by Application
12.2.2 Global Sustained-release Medicine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Sustained-release Medicine
1.2 Key Market Segments
1.2.1 Sustained-release Medicine Segment by Type
1.2.2 Sustained-release Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SUSTAINED-RELEASE MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Sustained-release Medicine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Sustained-release Medicine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SUSTAINED-RELEASE MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Sustained-release Medicine Product Life Cycle
3.3 Global Sustained-release Medicine Sales by Manufacturers (2020-2025)
3.4 Global Sustained-release Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Sustained-release Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Sustained-release Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Sustained-release Medicine Market Competitive Situation and Trends
3.8.1 Sustained-release Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Sustained-release Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SUSTAINED-RELEASE MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Sustained-release Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SUSTAINED-RELEASE MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Sustained-release Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Sustained-release Medicine Market
5.7 ESG Ratings of Leading Companies
6 SUSTAINED-RELEASE MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Sustained-release Medicine Sales Market Share by Type (2020-2025)
6.3 Global Sustained-release Medicine Market Size by Type (2020-2025)
6.4 Global Sustained-release Medicine Price by Type (2020-2025)
7 SUSTAINED-RELEASE MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Sustained-release Medicine Market Sales by Application (2020-2025)
7.3 Global Sustained-release Medicine Market Size (M USD) by Application (2020-2025)
7.4 Global Sustained-release Medicine Sales Growth Rate by Application (2020-2025)
8 SUSTAINED-RELEASE MEDICINE MARKET SALES BY REGION
8.1 Global Sustained-release Medicine Sales by Region
8.1.1 Global Sustained-release Medicine Sales by Region
8.1.2 Global Sustained-release Medicine Sales Market Share by Region
8.2 Global Sustained-release Medicine Market Size by Region
8.2.1 Global Sustained-release Medicine Market Size by Region
8.2.2 Global Sustained-release Medicine Market Size by Region
8.3 North America
8.3.1 North America Sustained-release Medicine Sales by Country
8.3.2 North America Sustained-release Medicine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Sustained-release Medicine Sales by Country
8.4.2 Europe Sustained-release Medicine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Sustained-release Medicine Sales by Region
8.5.2 Asia Pacific Sustained-release Medicine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Sustained-release Medicine Sales by Country
8.6.2 South America Sustained-release Medicine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Sustained-release Medicine Sales by Region
8.7.2 Middle East and Africa Sustained-release Medicine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SUSTAINED-RELEASE MEDICINE MARKET PRODUCTION BY REGION
9.1 Global Production of Sustained-release Medicine by Region(2020-2025)
9.2 Global Sustained-release Medicine Revenue Market Share by Region (2020-2025)
9.3 Global Sustained-release Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Sustained-release Medicine Production
9.4.1 North America Sustained-release Medicine Production Growth Rate (2020-2025)
9.4.2 North America Sustained-release Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Sustained-release Medicine Production
9.5.1 Europe Sustained-release Medicine Production Growth Rate (2020-2025)
9.5.2 Europe Sustained-release Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Sustained-release Medicine Production (2020-2025)
9.6.1 Japan Sustained-release Medicine Production Growth Rate (2020-2025)
9.6.2 Japan Sustained-release Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Sustained-release Medicine Production (2020-2025)
9.7.1 China Sustained-release Medicine Production Growth Rate (2020-2025)
9.7.2 China Sustained-release Medicine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Sustained-release Medicine Product Overview
10.1.3 Sanofi Sustained-release Medicine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Sustained-release Medicine Product Overview
10.2.3 Novartis Sustained-release Medicine Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Bayer
10.3.1 Bayer Basic Information
10.3.2 Bayer Sustained-release Medicine Product Overview
10.3.3 Bayer Sustained-release Medicine Product Market Performance
10.3.4 Bayer Business Overview
10.3.5 Bayer SWOT Analysis
10.3.6 Bayer Recent Developments
10.4 Johnson and Johnson
10.4.1 Johnson and Johnson Basic Information
10.4.2 Johnson and Johnson Sustained-release Medicine Product Overview
10.4.3 Johnson and Johnson Sustained-release Medicine Product Market Performance
10.4.4 Johnson and Johnson Business Overview
10.4.5 Johnson and Johnson Recent Developments
10.5 Takeda
10.5.1 Takeda Basic Information
10.5.2 Takeda Sustained-release Medicine Product Overview
10.5.3 Takeda Sustained-release Medicine Product Market Performance
10.5.4 Takeda Business Overview
10.5.5 Takeda Recent Developments
10.6 AstraZeneca
10.6.1 AstraZeneca Basic Information
10.6.2 AstraZeneca Sustained-release Medicine Product Overview
10.6.3 AstraZeneca Sustained-release Medicine Product Market Performance
10.6.4 AstraZeneca Business Overview
10.6.5 AstraZeneca Recent Developments
10.7 AbbVie
10.7.1 AbbVie Basic Information
10.7.2 AbbVie Sustained-release Medicine Product Overview
10.7.3 AbbVie Sustained-release Medicine Product Market Performance
10.7.4 AbbVie Business Overview
10.7.5 AbbVie Recent Developments
10.8 Pfizer
10.8.1 Pfizer Basic Information
10.8.2 Pfizer Sustained-release Medicine Product Overview
10.8.3 Pfizer Sustained-release Medicine Product Market Performance
10.8.4 Pfizer Business Overview
10.8.5 Pfizer Recent Developments
10.9 Collegium Pharmaceutical, Inc
10.9.1 Collegium Pharmaceutical, Inc Basic Information
10.9.2 Collegium Pharmaceutical, Inc Sustained-release Medicine Product Overview
10.9.3 Collegium Pharmaceutical, Inc Sustained-release Medicine Product Market Performance
10.9.4 Collegium Pharmaceutical, Inc Business Overview
10.9.5 Collegium Pharmaceutical, Inc Recent Developments
10.10 Endo Pharmaceuticals
10.10.1 Endo Pharmaceuticals Basic Information
10.10.2 Endo Pharmaceuticals Sustained-release Medicine Product Overview
10.10.3 Endo Pharmaceuticals Sustained-release Medicine Product Market Performance
10.10.4 Endo Pharmaceuticals Business Overview
10.10.5 Endo Pharmaceuticals Recent Developments
10.11 Shanghai Shyndec Pharmaceutical
10.11.1 Shanghai Shyndec Pharmaceutical Basic Information
10.11.2 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product Overview
10.11.3 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product Market Performance
10.11.4 Shanghai Shyndec Pharmaceutical Business Overview
10.11.5 Shanghai Shyndec Pharmaceutical Recent Developments
10.12 Zhuhai Rundu Pharmaceutical
10.12.1 Zhuhai Rundu Pharmaceutical Basic Information
10.12.2 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product Overview
10.12.3 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product Market Performance
10.12.4 Zhuhai Rundu Pharmaceutical Business Overview
10.12.5 Zhuhai Rundu Pharmaceutical Recent Developments
10.13 China Res Double-Crane
10.13.1 China Res Double-Crane Basic Information
10.13.2 China Res Double-Crane Sustained-release Medicine Product Overview
10.13.3 China Res Double-Crane Sustained-release Medicine Product Market Performance
10.13.4 China Res Double-Crane Business Overview
10.13.5 China Res Double-Crane Recent Developments
11 SUSTAINED-RELEASE MEDICINE MARKET FORECAST BY REGION
11.1 Global Sustained-release Medicine Market Size Forecast
11.2 Global Sustained-release Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Sustained-release Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Sustained-release Medicine Market Size Forecast by Region
11.2.4 South America Sustained-release Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Sustained-release Medicine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Sustained-release Medicine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Sustained-release Medicine by Type (2026-2035)
12.1.2 Global Sustained-release Medicine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Sustained-release Medicine by Type (2026-2035)
12.2 Global Sustained-release Medicine Market Forecast by Application (2026-2035)
12.2.1 Global Sustained-release Medicine Sales (K MT) Forecast by Application
12.2.2 Global Sustained-release Medicine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Sustained-release Medicine Market Size by Type (M USD)
Table 4. Global Sustained-release Medicine Market Size by Application
Table 5. Sustained-release Medicine Market Size Comparison by Region (M USD)
Table 6. Global Sustained-release Medicine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Sustained-release Medicine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Sustained-release Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Sustained-release Medicine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained-release Medicine as of 2025)
Table 11. Global Market Sustained-release Medicine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Sustained-release Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Sustained-release Medicine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Sustained-release Medicine Sales by Type (K MT)
Table 27. Global Sustained-release Medicine Market Size by Type (M USD)
Table 28. Global Sustained-release Medicine Sales (K MT) by Type (2020-2025)
Table 29. Global Sustained-release Medicine Sales Market Share by Type (2020-2025)
Table 30. Global Sustained-release Medicine Market Size (M USD) by Type (2020-2025)
Table 31. Global Sustained-release Medicine Market Share by Type (2020-2025)
Table 32. Global Sustained-release Medicine Price (USD/KG) by Type (2020-2025)
Table 33. Global Sustained-release Medicine Sales (K MT) by Application
Table 34. Global Sustained-release Medicine Market Size by Application
Table 35. Global Sustained-release Medicine Sales by Application (2020-2025) & (K MT)
Table 36. Global Sustained-release Medicine Sales Market Share by Application (2020-2025)
Table 37. Global Sustained-release Medicine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Sustained-release Medicine Market Share by Application (2020-2025)
Table 39. Global Sustained-release Medicine Sales Growth Rate by Application (2020-2025)
Table 40. Global Sustained-release Medicine Sales by Region (2020-2025) & (K MT)
Table 41. Global Sustained-release Medicine Sales Market Share by Region (2020-2025)
Table 42. Global Sustained-release Medicine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Sustained-release Medicine Market Size by Region (2020-2025)
Table 44. North America Sustained-release Medicine Sales by Country (2020-2025) & (K MT)
Table 45. North America Sustained-release Medicine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Sustained-release Medicine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Sustained-release Medicine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Sustained-release Medicine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Sustained-release Medicine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Sustained-release Medicine Sales by Country (2020-2025) & (K MT)
Table 51. South America Sustained-release Medicine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Sustained-release Medicine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Sustained-release Medicine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Sustained-release Medicine Production (K MT) by Region(2020-2025)
Table 55. Global Sustained-release Medicine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Sustained-release Medicine Revenue Market Share by Region (2020-2025)
Table 57. Global Sustained-release Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Sustained-release Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Sustained-release Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Sustained-release Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Sustained-release Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Sustained-release Medicine Product Overview
Table 64. Sanofi Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Sustained-release Medicine Product Overview
Table 70. Novartis Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Bayer Basic Information
Table 75. Bayer Sustained-release Medicine Product Overview
Table 76. Bayer Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bayer Business Overview
Table 78. Bayer SWOT Analysis
Table 79. Bayer Recent Developments
Table 80. Johnson and Johnson Basic Information
Table 81. Johnson and Johnson Sustained-release Medicine Product Overview
Table 82. Johnson and Johnson Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Johnson and Johnson Business Overview
Table 84. Johnson and Johnson Recent Developments
Table 85. Takeda Basic Information
Table 86. Takeda Sustained-release Medicine Product Overview
Table 87. Takeda Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Takeda Business Overview
Table 89. Takeda Recent Developments
Table 90. AstraZeneca Basic Information
Table 91. AstraZeneca Sustained-release Medicine Product Overview
Table 92. AstraZeneca Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Recent Developments
Table 95. AbbVie Basic Information
Table 96. AbbVie Sustained-release Medicine Product Overview
Table 97. AbbVie Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. AbbVie Business Overview
Table 99. AbbVie Recent Developments
Table 100. Pfizer Basic Information
Table 101. Pfizer Sustained-release Medicine Product Overview
Table 102. Pfizer Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Pfizer Business Overview
Table 104. Pfizer Recent Developments
Table 105. Collegium Pharmaceutical, Inc Basic Information
Table 106. Collegium Pharmaceutical, Inc Sustained-release Medicine Product Overview
Table 107. Collegium Pharmaceutical, Inc Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Collegium Pharmaceutical, Inc Business Overview
Table 109. Collegium Pharmaceutical, Inc Recent Developments
Table 110. Endo Pharmaceuticals Basic Information
Table 111. Endo Pharmaceuticals Sustained-release Medicine Product Overview
Table 112. Endo Pharmaceuticals Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Endo Pharmaceuticals Business Overview
Table 114. Endo Pharmaceuticals Recent Developments
Table 115. Shanghai Shyndec Pharmaceutical Basic Information
Table 116. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product Overview
Table 117. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Shanghai Shyndec Pharmaceutical Business Overview
Table 119. Shanghai Shyndec Pharmaceutical Recent Developments
Table 120. Zhuhai Rundu Pharmaceutical Basic Information
Table 121. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product Overview
Table 122. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Zhuhai Rundu Pharmaceutical Business Overview
Table 124. Zhuhai Rundu Pharmaceutical Recent Developments
Table 125. China Res Double-Crane Basic Information
Table 126. China Res Double-Crane Sustained-release Medicine Product Overview
Table 127. China Res Double-Crane Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. China Res Double-Crane Business Overview
Table 129. China Res Double-Crane Recent Developments
Table 130. Global Sustained-release Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global Sustained-release Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Sustained-release Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America Sustained-release Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Sustained-release Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe Sustained-release Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Sustained-release Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific Sustained-release Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Sustained-release Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America Sustained-release Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Sustained-release Medicine Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Sustained-release Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Sustained-release Medicine Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global Sustained-release Medicine Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Sustained-release Medicine Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global Sustained-release Medicine Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global Sustained-release Medicine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Sustained-release Medicine Market Size by Type (M USD)
Table 4. Global Sustained-release Medicine Market Size by Application
Table 5. Sustained-release Medicine Market Size Comparison by Region (M USD)
Table 6. Global Sustained-release Medicine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Sustained-release Medicine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Sustained-release Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Sustained-release Medicine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained-release Medicine as of 2025)
Table 11. Global Market Sustained-release Medicine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Sustained-release Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Sustained-release Medicine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Sustained-release Medicine Sales by Type (K MT)
Table 27. Global Sustained-release Medicine Market Size by Type (M USD)
Table 28. Global Sustained-release Medicine Sales (K MT) by Type (2020-2025)
Table 29. Global Sustained-release Medicine Sales Market Share by Type (2020-2025)
Table 30. Global Sustained-release Medicine Market Size (M USD) by Type (2020-2025)
Table 31. Global Sustained-release Medicine Market Share by Type (2020-2025)
Table 32. Global Sustained-release Medicine Price (USD/KG) by Type (2020-2025)
Table 33. Global Sustained-release Medicine Sales (K MT) by Application
Table 34. Global Sustained-release Medicine Market Size by Application
Table 35. Global Sustained-release Medicine Sales by Application (2020-2025) & (K MT)
Table 36. Global Sustained-release Medicine Sales Market Share by Application (2020-2025)
Table 37. Global Sustained-release Medicine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Sustained-release Medicine Market Share by Application (2020-2025)
Table 39. Global Sustained-release Medicine Sales Growth Rate by Application (2020-2025)
Table 40. Global Sustained-release Medicine Sales by Region (2020-2025) & (K MT)
Table 41. Global Sustained-release Medicine Sales Market Share by Region (2020-2025)
Table 42. Global Sustained-release Medicine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Sustained-release Medicine Market Size by Region (2020-2025)
Table 44. North America Sustained-release Medicine Sales by Country (2020-2025) & (K MT)
Table 45. North America Sustained-release Medicine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Sustained-release Medicine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Sustained-release Medicine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Sustained-release Medicine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Sustained-release Medicine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Sustained-release Medicine Sales by Country (2020-2025) & (K MT)
Table 51. South America Sustained-release Medicine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Sustained-release Medicine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Sustained-release Medicine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Sustained-release Medicine Production (K MT) by Region(2020-2025)
Table 55. Global Sustained-release Medicine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Sustained-release Medicine Revenue Market Share by Region (2020-2025)
Table 57. Global Sustained-release Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Sustained-release Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Sustained-release Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Sustained-release Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Sustained-release Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Sustained-release Medicine Product Overview
Table 64. Sanofi Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Sustained-release Medicine Product Overview
Table 70. Novartis Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Bayer Basic Information
Table 75. Bayer Sustained-release Medicine Product Overview
Table 76. Bayer Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bayer Business Overview
Table 78. Bayer SWOT Analysis
Table 79. Bayer Recent Developments
Table 80. Johnson and Johnson Basic Information
Table 81. Johnson and Johnson Sustained-release Medicine Product Overview
Table 82. Johnson and Johnson Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Johnson and Johnson Business Overview
Table 84. Johnson and Johnson Recent Developments
Table 85. Takeda Basic Information
Table 86. Takeda Sustained-release Medicine Product Overview
Table 87. Takeda Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Takeda Business Overview
Table 89. Takeda Recent Developments
Table 90. AstraZeneca Basic Information
Table 91. AstraZeneca Sustained-release Medicine Product Overview
Table 92. AstraZeneca Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Recent Developments
Table 95. AbbVie Basic Information
Table 96. AbbVie Sustained-release Medicine Product Overview
Table 97. AbbVie Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. AbbVie Business Overview
Table 99. AbbVie Recent Developments
Table 100. Pfizer Basic Information
Table 101. Pfizer Sustained-release Medicine Product Overview
Table 102. Pfizer Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Pfizer Business Overview
Table 104. Pfizer Recent Developments
Table 105. Collegium Pharmaceutical, Inc Basic Information
Table 106. Collegium Pharmaceutical, Inc Sustained-release Medicine Product Overview
Table 107. Collegium Pharmaceutical, Inc Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Collegium Pharmaceutical, Inc Business Overview
Table 109. Collegium Pharmaceutical, Inc Recent Developments
Table 110. Endo Pharmaceuticals Basic Information
Table 111. Endo Pharmaceuticals Sustained-release Medicine Product Overview
Table 112. Endo Pharmaceuticals Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Endo Pharmaceuticals Business Overview
Table 114. Endo Pharmaceuticals Recent Developments
Table 115. Shanghai Shyndec Pharmaceutical Basic Information
Table 116. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product Overview
Table 117. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Shanghai Shyndec Pharmaceutical Business Overview
Table 119. Shanghai Shyndec Pharmaceutical Recent Developments
Table 120. Zhuhai Rundu Pharmaceutical Basic Information
Table 121. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product Overview
Table 122. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Zhuhai Rundu Pharmaceutical Business Overview
Table 124. Zhuhai Rundu Pharmaceutical Recent Developments
Table 125. China Res Double-Crane Basic Information
Table 126. China Res Double-Crane Sustained-release Medicine Product Overview
Table 127. China Res Double-Crane Sustained-release Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. China Res Double-Crane Business Overview
Table 129. China Res Double-Crane Recent Developments
Table 130. Global Sustained-release Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global Sustained-release Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Sustained-release Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America Sustained-release Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Sustained-release Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe Sustained-release Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Sustained-release Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific Sustained-release Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Sustained-release Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America Sustained-release Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Sustained-release Medicine Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Sustained-release Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Sustained-release Medicine Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global Sustained-release Medicine Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Sustained-release Medicine Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global Sustained-release Medicine Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global Sustained-release Medicine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Sustained-release Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Sustained-release Medicine Market Size (M USD), 2025-2035
Figure 5. Global Sustained-release Medicine Market Size (M USD) (2020-2035)
Figure 6. Global Sustained-release Medicine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Sustained-release Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Sustained-release Medicine Product Life Cycle
Figure 13. Sustained-release Medicine Sales Share by Manufacturers in 2025
Figure 14. Global Sustained-release Medicine Revenue Share by Manufacturers in 2025
Figure 15. Sustained-release Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Sustained-release Medicine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Sustained-release Medicine Revenue in 2025
Figure 18. Industry Chain Map of Sustained-release Medicine
Figure 19. Global Sustained-release Medicine Market PEST Analysis
Figure 20. Global Sustained-release Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Sustained-release Medicine Market Share by Type
Figure 27. Sales Market Share of Sustained-release Medicine by Type (2020-2025)
Figure 28. Sales Market Share of Sustained-release Medicine by Type in 2025
Figure 29. Market Share of Sustained-release Medicine by Type (2020-2025)
Figure 30. Market Share of Sustained-release Medicine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Sustained-release Medicine Market Share by Application
Figure 33. Global Sustained-release Medicine Sales Market Share by Application (2020-2025)
Figure 34. Global Sustained-release Medicine Sales Market Share by Application in 2025
Figure 35. Global Sustained-release Medicine Market Share by Application (2020-2025)
Figure 36. Global Sustained-release Medicine Market Share by Application in 2025
Figure 37. Global Sustained-release Medicine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Sustained-release Medicine Sales Market Share by Region (2020-2025)
Figure 39. Global Sustained-release Medicine Market Size by Region (2020-2025)
Figure 40. North America Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Sustained-release Medicine Sales Market Share by Country in 2024
Figure 43. North America Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Sustained-release Medicine Market Size by Country in 2024
Figure 45. U.S. Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Sustained-release Medicine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Sustained-release Medicine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Sustained-release Medicine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Sustained-release Medicine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Sustained-release Medicine Sales Market Share by Country in 2024
Figure 53. Europe Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Sustained-release Medicine Market Size by Country in 2024
Figure 55. Germany Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Sustained-release Medicine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Sustained-release Medicine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Sustained-release Medicine Market Size by Region in 2024
Figure 68. China Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Sustained-release Medicine Sales and Growth Rate (K MT)
Figure 79. South America Sustained-release Medicine Sales Market Share by Country in 2024
Figure 80. South America Sustained-release Medicine Market Size and Growth Rate (M USD)
Figure 81. South America Sustained-release Medicine Market Size by Country in 2024
Figure 82. Brazil Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Sustained-release Medicine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Sustained-release Medicine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Sustained-release Medicine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Sustained-release Medicine Market Size by Region in 2024
Figure 92. Saudi Arabia Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Sustained-release Medicine Production Market Share by Region (2020-2025)
Figure 103. North America Sustained-release Medicine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Sustained-release Medicine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Sustained-release Medicine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Sustained-release Medicine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Sustained-release Medicine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Sustained-release Medicine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Sustained-release Medicine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Sustained-release Medicine Market Share Forecast by Type (2026-2035)
Figure 111. Global Sustained-release Medicine Sales Forecast by Application (2026-2035)
Figure 112. Global Sustained-release Medicine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Sustained-release Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Sustained-release Medicine Market Size (M USD), 2025-2035
Figure 5. Global Sustained-release Medicine Market Size (M USD) (2020-2035)
Figure 6. Global Sustained-release Medicine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Sustained-release Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Sustained-release Medicine Product Life Cycle
Figure 13. Sustained-release Medicine Sales Share by Manufacturers in 2025
Figure 14. Global Sustained-release Medicine Revenue Share by Manufacturers in 2025
Figure 15. Sustained-release Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Sustained-release Medicine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Sustained-release Medicine Revenue in 2025
Figure 18. Industry Chain Map of Sustained-release Medicine
Figure 19. Global Sustained-release Medicine Market PEST Analysis
Figure 20. Global Sustained-release Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Sustained-release Medicine Market Share by Type
Figure 27. Sales Market Share of Sustained-release Medicine by Type (2020-2025)
Figure 28. Sales Market Share of Sustained-release Medicine by Type in 2025
Figure 29. Market Share of Sustained-release Medicine by Type (2020-2025)
Figure 30. Market Share of Sustained-release Medicine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Sustained-release Medicine Market Share by Application
Figure 33. Global Sustained-release Medicine Sales Market Share by Application (2020-2025)
Figure 34. Global Sustained-release Medicine Sales Market Share by Application in 2025
Figure 35. Global Sustained-release Medicine Market Share by Application (2020-2025)
Figure 36. Global Sustained-release Medicine Market Share by Application in 2025
Figure 37. Global Sustained-release Medicine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Sustained-release Medicine Sales Market Share by Region (2020-2025)
Figure 39. Global Sustained-release Medicine Market Size by Region (2020-2025)
Figure 40. North America Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Sustained-release Medicine Sales Market Share by Country in 2024
Figure 43. North America Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Sustained-release Medicine Market Size by Country in 2024
Figure 45. U.S. Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Sustained-release Medicine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Sustained-release Medicine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Sustained-release Medicine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Sustained-release Medicine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Sustained-release Medicine Sales Market Share by Country in 2024
Figure 53. Europe Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Sustained-release Medicine Market Size by Country in 2024
Figure 55. Germany Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Sustained-release Medicine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Sustained-release Medicine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Sustained-release Medicine Market Size by Region in 2024
Figure 68. China Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Sustained-release Medicine Sales and Growth Rate (K MT)
Figure 79. South America Sustained-release Medicine Sales Market Share by Country in 2024
Figure 80. South America Sustained-release Medicine Market Size and Growth Rate (M USD)
Figure 81. South America Sustained-release Medicine Market Size by Country in 2024
Figure 82. Brazil Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Sustained-release Medicine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Sustained-release Medicine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Sustained-release Medicine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Sustained-release Medicine Market Size by Region in 2024
Figure 92. Saudi Arabia Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Sustained-release Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Sustained-release Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Sustained-release Medicine Production Market Share by Region (2020-2025)
Figure 103. North America Sustained-release Medicine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Sustained-release Medicine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Sustained-release Medicine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Sustained-release Medicine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Sustained-release Medicine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Sustained-release Medicine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Sustained-release Medicine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Sustained-release Medicine Market Share Forecast by Type (2026-2035)
Figure 111. Global Sustained-release Medicine Sales Forecast by Application (2026-2035)
Figure 112. Global Sustained-release Medicine Market Share Forecast by Application (2026-2035)
